CD274 and non-small cell lung carcinoma: In a retrospective analysis in patients enrolled in the KEYNOTE-042 evaluating pembrolizumab monotherapy vs platinum-based chemotherapy as the first-line therapy among patients with PD-L1-positive (TPS ≥1%) advanced non-squamous histology NSCLC, 301 patients were evaluable by whole-exome sequencing (WES).